Clinical Trial Update: Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing the potential atrophogenic effects of hydrocortisone 1% cream versus pimecrolimus 1% cream on uninvolved skin in atopic dermati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Hydrocortisone 1% cream (Hydrocortisone)
• Pimecrolimus 1% Cream (Pimecrolimus)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED